| 摘要: |
| 目的 探讨黏附 G 蛋白偶联受体 F4(ADGRF4)在胃癌组织中的表达水平,分析其与临床病理特征及患者预后的相关性,并阐明 ADGRF4 对胃癌细胞增殖、凋亡、迁移及侵袭等恶性生物学行为的调控作用。方法 收集 70 例胃癌组织及配对癌旁正常组织,采用免疫组化检测 ADGRF4 蛋白表达;结合 TCGA 数据库分析 ADGRF4 表达与胃癌患者生存预后的关系;构建 ADGRF4 稳定敲减的 HGC-27 和AGS细胞株,通过 CCK-8、EdU、Annexin V-FITC/PI 双染、集落形成、划痕实验及 Transwell 实验,检测敲低 ADGRF4 对胃癌细胞恶性表型的影响,并检测其对下游PPP4C蛋白表达的影响。结果 ADGRF4 在胃癌组织中呈显著高表达,其高表达与肿瘤低分化、神经侵袭、血管侵袭、深浸润、淋巴结转移及高临床分期密切相关,且与患者总生存期、无进展生存期及无病生存期缩短显著相关。体外实验显示,敲减 ADGRF4 可明显抑制 HGC-27 和AGS细胞增殖、克隆形成、迁移与侵袭能力,并显著促进细胞凋亡,同时下调PPP4C蛋白表达。且TCGA数据库分析显示胃癌组织中ADGRF4与PPP4C表达呈显著正相关。结论 ADGRF4 在胃癌中异常高表达,与肿瘤恶性进展及不良预后密切相关,ADGRF4可能通过调控PPP4C表达发挥促癌作用,可作为胃癌诊断、预后评估的潜在标志物及靶向治疗新靶点。 |
| 关键词: 胃癌 黏附G蛋白偶联受体F4-蛋白磷酸酶4催化亚基 细胞增殖 细胞凋亡 细胞迁移 细胞侵袭 预后 |
| DOI:10.13506/j.cnki.jpr.2026.06.001 |
| 基金项目:国家重点研发计划-青年科学家项目(No.2023YFC2812500);江苏省卫生健康委医学科研项目-指导性项目(No.Z2023098);句容市社会发展科技计划项目(No.ZA42313);南京医科大学科技发展基金项目(No.NMUB20240067) |
|
Received Date:March 17, 2026
Revision Date:May 06, 2026
|
|
| Expression and correlation of ADGRF4 in gastric cancer |
| SHEN Xudong1,2,BAO Lulu3,WANG Xing4,ZHU Yin5 |
| (1.Department of Pathology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028,China; 2.Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028,China; 3.Department of Obstetrics, Women's Hospital of Nanjing Medical University (Nanjing Women and Children’s Healthcare Hospital), Nanjing 210004,China; 4.Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 211198,China; 5.Department of General Practice, Jurong People Hospital, Jurong 212400,China) |
| Abstract: |
| Objective To investigate the expression level of adhesion G protein-coupled receptor F4 (ADGRF4) in gastric cancer tissues, analyze its correlation with clinicopathological features and prognosis, and clarify the regulatory effects of ADGRF4 on malignant biological behaviors such as proliferation, apoptosis, migration and invasion of gastric cancer cells.Methods Seventy cases of gastric cancer tissues and paired adjacent normal tissues were collected, and the expression of ADGRF4 protein was detected by immunohistochemistry. The correlation between ADGRF4 expression and survival prognosis of gastric cancer patients was analyzed based on TCGA database. HGC-27 and AGS cell lines with stable ADGRF4 knockdown were constructed. CCK-8, EdU, Annexin V-FITC/PI double staining, colony formation, wound healing assay and Transwell assay were used to detect the effects of ADGRF4 knockdown on malignant phenotypes of gastric cancer cells, and its effect on downstream PPP4C protein expression was also detected.Results ADGRF4 was significantly highly expressed in gastric cancer tissues. Its high expression was closely associated with poor differentiation, perineural invasion, vascular invasion, deep infiltration, lymph node metastasis and advanced clinical stage, and was significantly correlated with shorter overall survival, progression-free survival and disease-free survival. In vitro experiments showed that ADGRF4 knockdown significantly inhibited proliferation, colony formation, migration and invasion, and obviously promoted apoptosis of HGC-27 and AGS cells, and significantly downregulated PPP4C protein expression. Moreover, TCGA database analysis showed that the expression of ADGRF4 was significantly positively correlated with that of PPP4C in gastric cancer tissues. Conclusion ADGRF4 is abnormally highly expressed in gastric cancer, which is closely related to malignant progression and poor prognosis. ADGRF4 exerts a cancer-promoting effect by regulating PPP4C expression, which can be used as a potential biomarker for diagnosis and prognosis evaluation, as well as a novel target for targeted therapy of gastric cancer. |
| Key words: Gastric cancer ADGRF4-PPP4C axis Cell proliferation Cell apoptosis Cell migration Cell invasion Prognosis |